Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

204 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
ErbB receptors: directing key signaling networks throughout life.
Holbro T, Hynes NE. Holbro T, et al. Among authors: hynes ne. Annu Rev Pharmacol Toxicol. 2004;44:195-217. doi: 10.1146/annurev.pharmtox.44.101802.121440. Annu Rev Pharmacol Toxicol. 2004. PMID: 14744244 Review.
Memo mediates ErbB2-driven cell motility.
Marone R, Hess D, Dankort D, Muller WJ, Hynes NE, Badache A. Marone R, et al. Among authors: hynes ne. Nat Cell Biol. 2004 Jun;6(6):515-22. doi: 10.1038/ncb1134. Epub 2004 May 23. Nat Cell Biol. 2004. PMID: 15156151
Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins.
Koziczak M, Holbro T, Hynes NE. Koziczak M, et al. Among authors: hynes ne. Oncogene. 2004 Apr 29;23(20):3501-8. doi: 10.1038/sj.onc.1207331. Oncogene. 2004. PMID: 15116089
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, Hynes NE. Holbro T, et al. Among authors: hynes ne. Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8933-8. doi: 10.1073/pnas.1537685100. Epub 2003 Jul 9. Proc Natl Acad Sci U S A. 2003. PMID: 12853564 Free PMC article.
The ErbB receptors and their role in cancer progression.
Holbro T, Civenni G, Hynes NE. Holbro T, et al. Among authors: hynes ne. Exp Cell Res. 2003 Mar 10;284(1):99-110. doi: 10.1016/s0014-4827(02)00099-x. Exp Cell Res. 2003. PMID: 12648469 Review.
The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB, Hynes NE, Lane HA. Motoyama AB, et al. Among authors: hynes ne. Cancer Res. 2002 Jun 1;62(11):3151-8. Cancer Res. 2002. PMID: 12036928
Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers.
Yen L, Benlimame N, Nie ZR, Xiao D, Wang T, Al Moustafa AE, Esumi H, Milanini J, Hynes NE, Pages G, Alaoui-Jamali MA. Yen L, et al. Among authors: hynes ne. Mol Biol Cell. 2002 Nov;13(11):4029-44. doi: 10.1091/mbc.e02-02-0084. Mol Biol Cell. 2002. PMID: 12429844 Free PMC article.
ErbB2: From an EGFR Relative to a Central Target for Cancer Therapy.
Hynes NE. Hynes NE. Cancer Res. 2016 Jul 1;76(13):3659-62. doi: 10.1158/0008-5472.CAN-16-1356. Cancer Res. 2016. PMID: 27371737 No abstract available.
The 14-3-3σ tumor suppressor has multiple functions in ErbB2-induced breast cancer.
Hynes NE, Smirnova T. Hynes NE, et al. Cancer Discov. 2012 Jan;2(1):19-22. doi: 10.1158/2159-8290.CD-11-0317. Cancer Discov. 2012. PMID: 22585164
Potential for targeting the fibroblast growth factor receptors in breast cancer.
Hynes NE, Dey JH. Hynes NE, et al. Cancer Res. 2010 Jul 1;70(13):5199-202. doi: 10.1158/0008-5472.CAN-10-0918. Epub 2010 Jun 22. Cancer Res. 2010. PMID: 20570901 Review.
204 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback